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Abstract
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At elevated levels, homocysteine (Hcy, 1) is a risk factor for cardiovascular diseases, Alzheimer’s
disease, neural tube defects, and osteoporosis. Both 1 and cysteine (Cys, 3) are linked to
neurotoxicity. The biochemical mechanisms by which 1 and 3 are involved in disease states are
relatively unclear. Herein, we describe simple methods for detecting either Hcy or Cys in the
visible spectral region with the highest selectivity reported to date without using biochemical
techniques or preparative separations. Simple methods and readily available reagents allow for the
detection of Cys and Hcy in the range of their physiologically relevant levels. New HPLC
postcolumn detection methods for biological thiols are reported. The potential biomedical
relevance of the chemical mechanisms involved in the detection of 1 is described.

Introduction
Homocysteine and Cysteine in Human Health
Elevated plasma homocysteine (Hcy, 1) levels are associated with increased risk of
myocardial infarction, stroke, and venous thromboembolism.1 Hyperhomocysteinemia has
also been linked to increased risk of Alzheimer’s disease,2 neural tube defects,3
complications during pregnancy,4 inflammatory bowel disease,5 and osteoporosis.6
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The role of Hcy in disease is unclear. After many years of study and impressive progress, it
is still not yet known if Hcy causes disease, is a consequence of it, or is simply a
biomarker.1b There is an ongoing effort in the biomedical community involving the study of
hyperhomocysteinemia.1b
There is a compelling case for detecting and treating hyperhomocysteinemia in patients with
a history of premature cardiovascular disease, stroke, or venous thromboembolism.1b Hcy
also is of interest as an analyte for the screening of inborn errors of methionine metabolism.
Hcy monitoring is also useful in testing for folate and vitamin B12 deficiency.1b
Homocystinurics have up to 500 µM levels of total plasma Hcy (tHcy, free thiol plus
disulfide), including ca. 100 µM of freely circulating thiol. Patients with this disorder are
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prone to severe neurodegeneration and mental retardation, if left untreated. Frequent Hcy
monitoring is apparently important in such cases.1,7
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Unlike Hcy, the relatively more common biological thiols, such as glutathione (GSH, 2), are
typically associated with beneficial antioxidant activity. It is therefore important to
understand the differences between the fundamental chemistry of Hcy, its derivatives, and
other biothiols.
Elevated levels of both Hcy and cysteine (Cys, 3) have been associated with neurotoxicity.
In the case of Cys, this has been demonstrated in vivo in animals with immature blood –
brain barriers and in cultured neurons in vitro.8 Additionally, Cys-induced hypoglycemic
brain damage has been studied as an alternative mechanism to excitotoxicity.9 The reasons
for these effects on the brain are not completely clear.
Cys can be obtained as the final product of the transsulfuration pathway through Hcy
metabolism. The exceptionally poor water solubility of the disulfide cystine reduces its
excretion. It therefore accumulates either in urine (leading to cystinuria)10 or in various
organs of the body (e.g., the kidneys).11 Low levels of Cys are associated with slowed
growth, hair depigmentation, edema, lethargy, liver damage, muscle and fat loss, skin
lesions, and weakness.12 Cys detection is thus of interest.
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Current State-of-the-Art in Biothiol Analysis
The determination of specific thiols is often carried out in conjunction with separations.13
Derivatization with fluorescent reagents is typically used. Most of these reagents possess
universal electrophilic alkylating groups for reaction with sulfhydrils. They are not selective
and have several drawbacks and limitations (Table 1).14,15 There are nearly 50 thiol-reactive
reagents currently sold by Molecular Probes, Inc.15b There is thus great interest in
developing agents for detecting biothiols.
Innovative molecular probes for thiols have also been reported in the literature. These
include 1,1′-thiocarbonyl diimidazole, shown to derivatize Cys and penicillamine; however,
the adducts are detected at relatively short wavelength.16 Other very creative, recently
reported reagents promote thiol-induced signaling.17
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Refsum et al., as well as several others, have made pioneering advances in developing
HPLC assays toward Hcy and related biothiol analysis.13b These methods are used in largescale population studies that have been ongoing for 2 decades.13b Refsum et al. addressed
the issues of removing excess mono-bromobimane and other (unidentified) fluorescent
impurities prior to HPLC analyses in 1989.18 They used a chromatographic “heart-cut,” with
a column switching device and two-solvent delivery system. They later devised a convenient
automated system requiring less tedium, instrumental manipulation, and wear as compared
to their 1989 method.19 The retention times of the fluorescent impurity peaks caused by the
monobromobimane are highly pH-sensitive. The method works well on the basis of precise
control of mobile phase acidity and the relatively high fluorescence of the bimane – thiol
adducts.
The highly useful commercial immunoassays (e.g., the fluorescence polarization
immunoassay run on Abbott’s Imx and AxSYM platforms20) monitor one analyte at a time
and utilize relatively fragile biological materials. In certain studies, interlaboratory
imprecision with immunoassay methods has been reported.21 In addition, fluorescence
immunoassay reagents are relatively very expensive.15
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As stated by Refsum et al. in their comprehensive 2004 review coauthored by a group of the
world’s leading experts in this field, many analytical methods afford results that do not
fulfill baseline bias and imprecision criteria.13b Interlaboratory and inter- and intrapatient
errors in Hcy and biological thiol assays persist. There is a need for standardization. HPLC
monitoring with a universal thiol-derivatizing reagent affords simultaneous monitoring of
thiols, but it requires skilled staff and is labor intensive and throughput may be low.13b
Highly selective probes for Hcy and Cys are being developed in our lab as potentially useful
new detection agents.22 The selective colorimetric and fluorimetric detection of Cys and
Hcy in natural media is reported herein. New HPLC methods are also described. The study
of chemoselective probes promotes further understanding of the unique organic and
bioorganic chemistry of Hcy and Cys.

Results and Discussion
Thiazolidines as Stable, Readily Formed Cys and Hcy Adducts
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It has been known for nearly 80 years that carbonyls react with Cys.23 N-Terminal Cys
residues react readily with aldehydes to form thiazolidines.24 The products are stable even at
slightly acidic pH in aqueous solvents. Thiazolidine formation has been effectively used in
modern ligation reactions.25 N-Teminal oxazolidines (i.e., heterocycles derived from the
reaction of serine and aldehydes) are 104 times less stable than Cys-derived thiazolidines.25
Thiazolidine Reactions for the Detection of Cys and Hcy
The synthesis of dialdehyde 6a was initially described by Lippard et al.26 Compound 6a as
well as monoaldehyde 6b are synthesized in our lab in one step via a Reimer – Tieman
reaction of commercial fluorescein. Single-crystal X-ray structure analysis confirms the
structure assignment of 6a and 6b (Scheme 1).
Upon addition of Cys or Hcy to a solution of 6a, a solution color change from bright yellow
to brownish-orange can be observed.22a Similar color changes are observed on C18-bonded
silica.22a Healthy plasma tHcy concentrations are less than ca. 12 – 15 µM. Plasma Cys
concentrations are typically 20 – 30 times that of Hcy. Our previous studies22a show that
Cys-6a solutions can be monitored in the 10−5 – 10−6 M Cys concentration range. Cys
addition to a solution of 6a produces a 25-nm red shift.22a Addition of Cys to solutions of 6a
also results in monitorable fluorescence quenching.22a The reaction of Cys or Hcy with 6a
affords thiazolidines or thiazinanes, respectively (Cys 7a, Hcy 7b heterocyclic adducts,
Scheme 1).22a Their structures have been confirmed.22a
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UV – vis absorbance spectra of solutions containing 6a and other sulfur-containing
compounds (L-methionine, mercaptoethanol, GSH), other amino acids (L-glutamine, L-serine,
glycine, L-glutamic acid), and amines (D-glucosamine HCl and CH3NH2) (8 × 10−4 M, pH
9.5) confirm the high selectivity of 6a for Cys and Hcy.22a Solutions containing 6a and
bovine serum albumin or urease likewise exhibit only relatively insignificant absorbance
decreases.22a No red shift occurs upon addition of any of the aforementioned potential
interferents, even when added at 10-fold higher concentrations relative to Cys.22a
Additionally, UV – vis absorbance spectral changes are observed upon adding Cys to human
blood plasma samples containing 6a that are similar to those seen in buffer solution.22a
Fluorescence quenching is also observed upon titrating a solution of 6a in plasma with Cys
and Hcy.22a Barbas et al. have subsequently used aldehyde-functionalized dyes to promote
solution emission intensity increases in response to Cys.17e We find that solutions
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containing 6a or 6b exhibit moderately greater fluorescence quenching in response to Cys as
compared to Hcy.27
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Highly Selective Colorimetric Cys Detection Using a Commercially Available Aldehyde
Commercially available 4-nitrocinnamaldehyde (8a), cinnamaldehyde (8b), and 4-(N,Ndimethylamino) cinnamaldehyde (8c) are a series of prototypical α,β-unsaturated aldehyde
substrates with decreasing electrophilicity. Potentially heightened selectivity for Cys over
Hcy is predicted. Cys may form generally more favored 5- (or possibly 7-) membered ring
heterocycles, as compared to Hcy (6- or possibly 8-membered ring formation, respectively),
upon reaction with α,β-unsaturated aldehydes.28a
The least reactive electrophile, 8c, exhibits the highest Cys selectivity.27 A solution color
change from yellow to colorless is observed in 10 min after addition of Cys (1.0 × 10−3 M)
to a solution of 8c (1.0 × 10−6 M, carbonate buffer, pH 9.5). Hcy did not cause any color
change under these conditions (Figure 2).
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We observe complete conversion to 9b by 1H NMR after 1 h for the reaction of Cys (0.46
M) and 8c (3.4 × 10−2 M) in D2O (0.5 mL) containing 30% NaOD (0.001 mL) (see Figure
S13, Supporting Information). This transformation is confirmed via the disappearance of the
aldehyde signal at 9.5 ppm and subsequent appearance of the thiazolidine resonances
(proton b, Scheme 2) centered at δ 6.7 ppm. Olefin proton resonance c can be clearly
observed (dd, J = 16, 8.3 Hz, 1H) appearing 0.4 ppm upfield relative to the corresponding
resonance in 8c. Under similar conditions, Hcy reacts with 8c to form imine 9a in trace
amounts as the only observed product by 1H NMR.27 The 1H NMR resonance for the Schiff
base proton (carbon a, Scheme 2) is centered at δ = 8.01 ppm, in agreement with analogous
imine-forming controls using 8c and other substrates.28b
The specificity of 8c for Cys should be useful in the determination of Cys in a background
that may have structurally related compounds, such as biological samples also containing
Hcy and other amino acids. Where probes specific for different compounds have distinct
spectral ranges, they may be used together for determining different compounds
simultaneously. For example, the 400-nm absorption of 8c does not overlap substantially
with the 500-nm absorption for 6a. Thus, 8c may be used in conjunction with 6a to detect
Cys alone at 400 nm and total Cys plus Hcy at 500 nm. The concentration of Hcy may then
be inferred as [Hcy] = [Hcy + Cys] − [Cys]. We demonstrate a related approach in a new
fluorescence assay for Hcy (vide infra).
Site-Specific Peptide Labeling
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There is current interest in the site-specific labeling of peptides and proteins via either
existing or engineered N-terminal Cys residues.29 The fluorophores used include fluorescein
or NIR dyes with appended thioester moieties.29 Pretreatment of peptides with O-methylhydroxylamine is needed to free the terminal Cys residues that may exist as thiazolidines
due to reactions with carbonyl moieties of metabolites (thiazolidine formation is chemically
reversible).29 The thioester labeling reactions may require the use of additional reagents that
can impact protein folding.29 The ligations typically require thiol cofactors such as
thiophenol or benzylmercaptan.29 They are subject to thioester hydrolytic instability and
side reactions.29 We find that our aldehydeappended-dye techniques may find broader use in
forming reversible and strong, covalent site-specific (N-terminal cysteine) fluorescent labels.
Solutions containing Cys-Gly exhibit spectrophotometric responses similar to those of Cys
(Figure 3), while those containing Gly-Gly do not exhibit spectral changes (see Figure S5,
Supporting Information).

J Am Chem Soc. Author manuscript; available in PMC 2012 June 29.
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Highly Selective Fluorescence Detection of Hcy Including Minimal Sample Pretreatment
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We do not observe significant fluorescence emission in the visible wavelength region from
8c and its Cys adduct(s) in buffer solution. We should thus be able to use 8c in a complex
matrix to react with Cys to form relatively nonfluorescent products. In contrast, 6a exhibits
high fluorescence emission in the visible region that quenches due to the presence of both
Cys or Hcy (vide supra). We thus propose treating complex samples initially with 8c
followed by 6a. In this manner, 8c will react with Cys, leaving Hcy free to react with 6a.
Only fluorescence signaling due to Hcy should then be observed.
In deproteinized plasma spiked with (i) Cys or (ii) a combination of Cys and Hcy, and
pretreated with 8c, fluorescence quenching of 6a is due to Hcy concentration changes only
(Figure 4). Thus, sample treatment with Cys-selective 8c, nonabsorbing at 470 nm, is a
simple way to enhance selective Hcy detection at another wavelength with other aldehydefunctionalized probes.
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We show that this method can be used in relatively more complex native plasma solutions.
Commercial lyophilized plasma is simply reconstituted in buffer (pH 9.5). No
deproteinization steps are performed. Hcy concentration-dependent emission changes are
observed over a range of healthy (6 µM) to dangerous levels (1.3 × 10−4 M) levels, even in
the presence of added excess Cys (Figure 5). Optimization of sensitivity is needed and is
underway. We are studying near-infrared absorbing probes and other simple sample
pretreatments.
The Redox Chemistry of Biological Thiols and Selective Hcy Detection
Biological thiols can be oxidized in nature to thiyl radicals via well-studied processes.30 The
ensuing fate of these oxidizing radicals is of concern to public health. Two of the many
characteristic reactions of thiyl radicals include the formation of a reducing disulfide radical
anion (eq 1)
(1)

and the formation of a reducing α-amino carbon-centered radical (eq 2).
(2)

The analogous process in eq 2, which proceeds intermolecularly, is involved in “repairing”
processes targeting the carbon-centered radicals of biomolecules.30
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The formation of the α-amino alkyl radical of Cys was reported in 1971 by Neta.31 It was
later described that the α-amino alkyl radical of GSH could be formed intramolecularly via
the thiyl radical (as in eq 2).32,33 Zhao et al. reported in 1994 that intramolecular formation
of captodatively stabilized α-amino alkyl radical in Hcy should be particularly favorable.33a
This was attributed to an intramolecular hydrogen abstraction mechanism, which involves a
favored 5-membered ring transition state (Scheme 3).33a Armstrong and co-workers have
also made recent contributions concerning proton abstraction of thiyl radicals. They state
that during biological repair processes, GSH thiyl radical can undergo either an inter- or an
intramolecular process to form a carbon-centered radical with relatively equal ability.34
The dication methyl viologen (10) was used by Zhao et al. during thorough investigations of
the equilibrium kinetics of the reducing disulfide (eq 1) and the reducing α-amino
carboncentered radicals (eq 2) derived from the Hcy, Cys, and GSH thiyl radicals.33 The
formation of reducing radicals was monitored via changes in the UV – vis absorbance

J Am Chem Soc. Author manuscript; available in PMC 2012 June 29.
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spectra, indicating the production of the methyl viologen radical cation.33a Under the basic
conditions used (pH 10.5), no colorimetric selectivity among GSH, Cys, and Hcy was
observed.
At neutral solution pH, thiolate anion concentration is only a fraction of that of protonated
thiol. Thus, at neutral pH, reducing disulfide radical anion formation should be diminished
(eq 1). The hydrogen atom (intramolecular proton-coupled electron) transfer process
occurring via hydrogen atom abstraction, eq 2, which is most favored for Hcy (Scheme 3),
should become more predominant at physiological pH.
Additionally, zwitterionic amino acids cannot captodatively stabilize α-amino carboncentered radicals. When the ammonium moiety is deprotonated under alkaline conditions,
rearrangement to captodatively stabilized carbon-centered radicals occurs much more
readily and hence less selectively. We therefore reason that the formation of the reducing αamino alkyl radical should occur more readily in the case of Hcy compared to all other
thiols, at neutral, rather than alkaline pH.
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Upon heating respective colorless solutions of 10 (8.0 mM, pH 7.5, 0.5 M Tris buffer)
containing specific biological thiols (8.0 mM) at reflux for 5 min, without protection from
ambient air or light, visual signaling occurs selectively only for Hcy. The solution
containing Hcy can be readily seen to turn blue, from colorless (Scheme 4). The color
formation can be monitored via the appearance of absorptions at 398 and 605 nm. Solutions
of 10 containing Cys or GSH remain completely colorless upon heating.22b
Common thiol determinations in plasma often require a deproteinization step after the
reduction of disulfides to release the free thiols for analysis. Under our conditions, we find
that deproteinization after reduction may not be necessary. Commercial plasma samples,
spiked with Hcy, Cys, and GSH, upon heating in the presence of 10, afford selective blue
color formation only corresponding to the presence of Hcy (Figure 6) under similar
conditions as those described above. This result is completely consistent with our prior
results in buffer solutions.22b It demonstrates that deproteinization procedures such as
centrifugation may not be necessary in this determination technique, thereby potentially
allowing for relatively facile sample pretreatment. Work on optimizing detection limit and
sensitivity is continuing.
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To extend the scope and generality of selective Hcy detection, we use electron-accepting
fluorone black (11, Scheme 4), a commercially available xanthene dye, to confirm the Hcy
selectivity observed with 10. Upon addition of 10 equiv of Hcy (1.0 × 10−4 M final
concentration) to a solution of 11 (1.0 × 10−5 M) in 70% MeOH:H2O (MeOH is used for
solubility) at pH 7.3, a change (increase) in absorbance at 510 nm is observed at room
temperature. A similar, but relatively smaller, absorbance change is observed for Cys, GSH,
and penicillamine (Figure 7). Other amino acids (glycine, alanine, serine, methionine,
glutamine, lysine, arginine, threonine) and the disulfide homocystine do not promote a
detectable absorbance change.22b
The disulfide reduction in biological samples is often accomplished with a reducing agent
such as a phosphine. We investigate the effect of PPh3 on this process, initially in order to
mimic the conditions used to prepare biological samples for analysis via disulfide reduction.
When PPh3 (45 equiv to dye 11) is present in the dye solution, an absorbance change only
occurs in the presence of Hcy. No change is observed for Cys or other biological thiols.22b
Concentration-dependent dye absorbance increases are thus observed only for Hcy.22b In
addition, we observe selective fluorescence emission increases corresponding to the
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presence of Hcy under these conditions. No response is observed for Cys (see Figure S7,
Supporting Information).
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Interestingly, the UV – vis absorbance spectrum of a buffered solution of 11 with only
added PPh3 exhibits absorbance increases in a similar fashion as it does when Hcy is added.
This suggests that the phosphine may act as a competing reducing agent. We find that 11
enhances O=PPh3 formation, in a solution of 11 and PPh3, as monitored via 31P NMR
spectroscopy. After 19 h, O=PPh3 formation is not observed in PPh3 solution that does not
contain 11. In a PPh3 solution that contains 11, O=PPh3 formation is clearly observed.
O=PPh3 formation is well-known to proceed via the PPh3 radical cation. Thus, PPh3 inhibits
the reduction of 11 with thiols other than Hcy by acting as a competing reducing agent.
Hcy can serve as the best reducing agent in the series 1 – 5. At least 45 equiv PPh3 (to dye)
is needed to suppress the interactions of other thiols with 11. This is the threshold level of
competing reducing PPh3 that allows for only Hcy-generated spectrophotometric changes in
solutions of 11 – PPh3. If a 30-fold molar excess of Cys (to Hcy) is added to a solution of
Hcy (1.0 × 10−5 M, approximating both Hcy and Cys levels in plasma), 11 (1.0 × 10−5 M),
and PPh3 (1.5 × 10−3 M), no change in the spectrum compared to the original Hcy – 11
solution is observed.22b
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We successfully use the standard addition method to determine Hcy in a commercial sample
of human blood plasma.22b The calibration curve exhibits linearity in the working range
from 0 to 15 µM. The percent recovery of Hcy is 102.9 = 7.3%. The relative standard
deviation (RSD) is 7.1% (n = 3).22b
Solutions of fluorescein, unlike 11, do not exhibit spectral changes in response to Cys or
Hcy (Figure S10, Supporting Information). We thus propose that the formation of
semiquinone radical in 11 is responsible for the signal changes observed (Scheme 4).
Electron-transfer results in raising the pKa of the dye, as this corresponds to the absorbance
increase of the dye at 510 nm that occurs upon addition of base.
The Fate of the α-Amino Carbon-Centered Radical of Hcy
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The study of metabolites of Hcy is of great importance (vide supra). Amino acid-derived
free radicals are often implicated in DNA damage and the pathogenesis of disease. The
readily formed Hcy alkyl radical might be a significant site of free radical damage initiation
or propagation. We thus extend our prior work in the study of byproducts formed from the
Hcy carbon-centered radical under ambient conditions (our fluorone black 11 assay).22b It
has been reported that α-amino acid alkyl radicals form NH3 and several other radical
termination and disproportionation products under ionizing radiation and relatively harsh
oxidizing conditions.33,35
Several byproducts of Hcy alkyl radical reactions are identified under our assay conditions
at room temperature by using MALDI-TOF MS (Table 2). Scheme 5 shows a proposed
mechanism of formation of these products. Interestingly, compounds 13 and 18 have been
found in the urine of patients with homocystinuria.36 It is possible that peroxide intermediate
12 could be the oxidant itself that plays a role along with 14 in the formation of disulfide 13.
Thus, this study may provide a starting point as a chemical model for the reactions of the αamino carbon-centered radical derived from Hcy in the human body under nonradiative
conditions.

J Am Chem Soc. Author manuscript; available in PMC 2012 June 29.
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Effect of Transition Metals on the Detection of Hcy
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The oxidation of amino acids is generally catalyzed by transition metals. The mechanism of
this process involves the formation of hydroxyl radicals (Fenton reaction). Therefore, studies
of the oxidation of amino acids can be complicated by the presence of metal impurities in
buffers and reagents. We thus investigate the effects of a chelating agent (EDTA) and an
added transition metal (Fe3+) under our conditions, for completeness.
EDTA is a commonly used metal-chelating agent in studies of metal-catalyzed amino acid
oxidation reactions. In a study of Fenton chemistry, Stadtman et al. showed that the
oxidation of amino acids could be either stimulated or inhibited by various metal chelating
agents, depending on the actual ratios of chelating agents to iron salts.35 The varying amino
acid oxidation or inhibition of oxidation corresponding to changes in the ratios of chelating
agents to iron salts was attributed to variations in the composition, concentration, and redox
potentials of the different complexes.
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Upon addition of EDTA (20 equiv to 11) in our fluorone black assay, no differences in the
UV – vis absorbance spectra are observed as compared to our standard techniques without
EDTA (see Figure S8, Supporting Information). In addition, we find that no spectral
changes occur upon addition of FeCl3 (1.0 × 10−5 M) under the same conditions (without
EDTA; Supporting Information, Figure S9). The conclusion is that the mechanism shown in
Scheme 3 best accounts for the observed Hcy selectivity in our assays, rather than Fenton
chemistry.
Automated Postcolumn HPLC Detection of Hcy in Human Plasma
Recently, we have developed a simple HPLC post-column detection system for the analysis
of mono- and oligosaccharides based on a boronic acid-derived chemosensor.37 Postcolumn
detection allows for automation of the derivatization step and minimizes sample processing
prior to analysis. Major concerns with introducing any new postcolumn techniques include
(i) attaining appropriate reaction kinetics for generating an observable signal as well as (ii)
diminishing background interference. Herein, we demonstrate the use of a library of
aminothiol chemoselective reagents in a straightforward HPLC postcolumn detection
format.
Figure 8 shows that using 10 as a postcolumn detection reagent results in the detection of
Cys and Hcy (85 nmol each) at 610 nm. Figure 9a shows two sharp peaks corresponding to
Cys and Hcy (28.8 nmol each) using 11 as a chromogenic reagent (505 nm). The same
amount of six other selected amino acids (histidine, methionine, glutamine, lysine, glycine,
and serine) was injected (Figure 9b,c) and no peaks were observed.
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Figure 10a shows that two sharp peaks upon the co-injection of Cys and Hcy (43 nmol each)
were observed with 6a as the postcolumn reagent. In addition, resolution is improved by
switching the mobile phase to aqueous TFA (Figure 10b).
We also use compound 6a as a postcolumn reagent for the detection of Hcy in human
plasma. We observe that the Hcy peak appears at 5.3 min (Figure 11b). The injection of
twice the amount of unspiked plasma sample (Figure 11a) shows no interfering peak at 5.3
min. In addition, the Cys peak is wellresolved from that of Hcy, eluting at 3.6 min (Figure
S11, Supporting Information). This primary screen of a small library of probes with
aldehyde groups or electron-accepting properties shows the feasibility for the HPLC
postcolumn detection of biological thiols. Such compounds may serve as alternatives to
currently used electrophilic probes.
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The Stability of Fluorescein Dialdehyde 6a
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Widely used monobromobimane is unstable in water and must be stored in solution at less
than −20 °C. The solutions must be replaced regularly. Batch-to-batch impurity levels vary
significantly, presumably due to its instability (Table 1). Compound 6a (10−6 M) in 0.1 M
carbonate buffer was stored for 2 weeks at room temperature in solution under ambient light.
Minimal photobleaching is observed, only after 10 days (see Supporting Information, Figure
S6).
The above HPLC studies demonstrate that (i) postcolumn reaction kinetics are fast enough
for Hcy to be readily detected in all cases studied to date and (ii) the primary work with
native plasma necessitates only simple sample pretreatment. It involves addition of TFA and
rapid (seconds) syringe filtration (no centrifugation step). We obtain a chromatogram with a
promising degree of resolution of the Hcy peak from plasma matrix peaks.

Conclusion
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In conclusion, the unique ability of Hcy to form reducing carbon-centered radicals has led to
the development of the first Hcy-selective probes, 10 and 11. The interaction of Cys with
indicator 8c has afforded the most simple and selective Cys detection method reported to
date. The indicators described herein can also be used in combination to achieve heightened
selectivity for specific biothiols. They serve as highly chemo-selective alternatives to
currently available thiol-reactive probes. Their use as HPLC detection reagents has thus far
shown potential advantages. Currently, optimization and interlaboratory method validation
are still ongoing.
The identification of several Hcy free-radical-derived intermediates and the mechanism of
their formation as shown in Scheme 5 may help guide biomedical researchers in
understanding the fate of Hcy under physiological conditions. For instance, rare metabolites
such as 13, found in the urine of homocystinurics, were detected via the mild oxidation of
Hcy at room temperature under our assay conditions. Our studies of the free radical
chemistry of Hcy should complement the pioneering work by Jacobsen and co-workers, who
previously demonstrated the unique ability of Hcy to selectively target biomolecules.1a
Furthermore, studies by Jakubowski have shown that protein N-homocysteinylation (i.e., the
amide-forming reaction of homocysteine thiolactone with lysine residues) may cause
significant protein damage in humans.38 Thiazinane and free radical chemistry may aid the
study of Hcy-N-proteins, since the 1,3-aminothiol moiety is free to promote reactions.
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Our assays and associated NMR investigations demonstrate that Cys and Hcy can exhibit
differing reactivities toward specific aldehyde-derived substrates. This may have
implications in their respective roles in collagen disease, the inhibition of dopamine βhydrolase, the inhibition of pyridoxal-P enzymes, and other essential carbonyls.38 The
results shown in Figure 3 demonstrate feasibility of effectively labeling or detecting Nterminal cysteine-containing biomolecules. The further study of the unique chemical
reactivity of Cys, Hcy, and related compounds will be reported in due course.

Experimental Section
General
All chemicals were purchased from Sigma-Aldrich or Cambridge Isotope Labs and used
without further purification. Lyophilized blood plasma was reconstituted with H2O. All
spectroscopic data were acquired at room temperature. UV – vis data were obtained using a
Spectramax Plus 384 spectrophotometer (Molecular Devices). Matrix-assisted laser
J Am Chem Soc. Author manuscript; available in PMC 2012 June 29.
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desorption ionization mass spectra were acquired using a Bruker Proflex III MALDI mass
spectrometer with and without matrix (anthracene or dithranol). Fluorescence spectra were
recorded using a spectrofluorimeter SPEX Fluorolog-3 equipped with double excitation and
emission monochromators and 400-W Xe lamp. NMR spectra were acquired on a Bruker
DPX-250 or DPX-300 spectrometer. 1H and 13C NMR spectra were obtained using CD3OD,
D2O, DMSO-d6. 31P NMR spectra were acquired in 70% CD3OD, 30% D2O, unless
otherwise indicated. HPLC experiments were performed with a CM4000 multiple solvent
delivery system (LDC/Milton Roy) and a SpectroMonitor 3100 UV – vis detector (LDC/
Milton Roy) using a Lichrospher reverse-phase column (4.6 × 250 mm, 5 µm; Alltech
Associates Inc.). The postcolumn detection system consisted of a He cylinder connected to a
RDR-1 reagent delivery/reaction module (Timberline). The RDR-1 unit contains a
pressurized reagent reservoir, a mixing tee, and a thermostated reaction block with a Teflon
reaction coil (0.02 in. i.d. × 3 m). The HPLC column was connected to the RDR-1. The
RDR-1 was attached to a SpectroMonitor 3100 UV – vis detector (LDC/Milton Roy). The
temperature of the reaction block was set to 80 °C. Absorbance was monitored at 510 nm for
compound 6a, 610 nm for compound 10, and 505 nm for compound 11.
Synthesis of Compounds 6a and 6b
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Fluorescein (2.5 g, 7.75 mmol) and 3 mL of MeOH are placed in a 100 mL three-neck
round-bottom flask. Next, 10 g of 50% NaOH solution, 2.42 mL (30 mmol) of CHCl3, and
0.03 mL of 15-crown-5 are carefully added while the reaction temperature is maintained at
55 °C. The mixture is stirred at this temperature for 5 h. After cooling, the mixture is
acidified with 10 M H2SO4. The product precipitates. The solid is filtered and dried in vacuo
overnight. Chromatography on silica gel (15:85 EtOAc:DCM) yields a white solid (6a) and
a light yellow solid (6b). The yield for 6a is 92 mg (3.1%) and for 6b is 952 mg (34.1%).
TLC: 6a Rf = 0.55 (15:85 EtOAc:DCM), 6b Rf = 0.28 (15:85 EtOAc:DCM).
Characterization data for 6b. 1H NMR (DMSO-d6, 250 MHz) δ (ppm): 6.60 (2H, s), 6.68
(1H, d, J = 8.9 Hz), 6.84 (1H, s), 6.92 (1H, d, J = 8.9 Hz), 7.29 (1H, d, J = 7.5 Hz), 7.69 (1H,
m, J = 1.1, 7.5 Hz), 7.77 (1H, m, J = 1.1, 7.5 Hz), 7.99 (1H, d, J = 7.5 Hz), 10.26 (1H,S),
10.62 (1H, s), 11.87 (1H, s). 13C NMR (DMSO-d6, 300 MHz) δ (ppm): 81.29, 102.75,
109.20,109.27, 109.75, 113.48, 113.63, 124.06, 124.89, 125.97, 129.07, 130.42, 135.91,
136.61, 150.94, 152.25, 152.46, 159.71, 163.04, 168.68, 192.94. FTIR (KBr, cm−1): 1007,
1112, 1157, 1227, 1465, 1512, 1593, 1648, 1721, 3271. MALDI-TOF: m/z, 361.155 [M +
H]+, 383.242 [M + Na]+.
Detection of Hcy in Deproteinized Plasma Samples

NIH-PA Author Manuscript

Lyophilized commercial blood plasma samples are reconstituted in 0.1 M carbonate buffer
(pH 9.5) in one-third of the reconstitution volume. To the solution is added MeCN to attain
the final reconstitution volume. The solution is exposed for 30 min at room temperature to
precipitate proteins. The mixture is filtered through a 0.45 µm HPLC filter after
centrifugation at 5000 rpm. Cys is added to achieve a final concentration of 1.3 × 10−4 M.
Hcy is added in amounts up to 6.5 × 10−4 M. Solutions of 8c in MeOH (0.2 mL) are added
to the plasma samples to a final concentration equal to that of Cys. Samples are stirred at
room temperature for 20 min. Next, a solution of 6a (1.7 × 10−7 M) in 0.1 M carbonate
buffer (pH 9.5, 10 µL) is added. After stirring at room temperature for 20 min, the
fluorescence spectra are recorded.
Detection of Hcy in Native (Nondeproteinized) Plasma Samples
Lyophilized commercial blood plasma samples are reconstituted in 0.1 M carbonate buffer,
pH 9.5, as indicated on the label. Cys is added to achieve a final concentration of 1.3 × 10−4
M. Hcy is added in amounts up to 1.3 × 10−4 M. Solutions of 8c in MeOH (0.2 mL) are
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added to the plasma samples to a final concentration equal to that of Cys. Samples are stirred
at room temperature for 20 min. Next, a solution of 6a (1.7 × 10−7 M) in 0.1 M carbonate
buffer (pH 9.5, 10 µL) is added. After stirring at room temperature for 20 min, the
fluorescence spectra are recorded.
Detection of Hcy in Human Blood Plasma Using 10
Three 0.5-mL aliquots of reconstituted human blood plasma are spiked with Hcy, Cys, and
GSH (800 µM), respectively. Each spiked sample is mixed with 0.5 mL of a solution of 10
in Tris buffer (0.5 M, pH 7.5). The samples are refluxed on a hot plate until a blue color
forms in the Hcy-containing solution (5 min).
Effect of EDTA on the Detection of Hcy with 11
A 0.2-mL aliquot of a solution containing EDTA in 0.05 M, pH 7.3 phosphate buffer
(EDTA final concentration is 2.0 × 10−4 M) is added to 0.1 mL of a solution of Hcy in the
phosphate buffer (Hcy final concentration is 1.0 × 10−4 M). The mixture is stirred for 5 min.
The UV – vis absorbance spectrum is acquired after the addition of a 0.7-mL MeOH
solution containing 11 (final concentration of 11 is 1.0 × 10−5 M) to the solution of EDTA
and Hcy.
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Effect of Fe3+ on the Detection of Hcy with 11
To a solution of Hcy (1 × 10−4 M) in 0.05 M, pH 7.3 phosphate buffer (0.3 mL) is added 0.1
mL of a MeOH solution of FeCl3 (1.0 × 10−5 M). After addition of 0.6 mL of a MeOH
solution of 11 (1.0 × 10−5 M) to the solution containing Hcy and FeCl3, the UV – vis
absorbance spectrum is acquired. All concentrations denoted above are final solution
concentrations.
Initial Evaluation of Fluorone Black (11) as a Postcolumn Reagent
Conditions for chromatogram in Figure 9: mobile phase, 100% of HPLC grade water;
mobile phase flow rate, 1.5 mL/min; reagent, compound 11 (1.25 × 10−5 M) in 50/50 (v/v)
mixture of MeOH and aqueous carbonate buffer (0.25 M, pH 9.5); reagent delivery pressure,
40 psi; reactor temperature, 80 °C; detector wavelength, 505 nm.
Initial Evaluation of Methyl Viologen (10) as a Postcolumn Reagent
Conditions for chromatogram in Figure 8: mobile phase, TFA 0.01 M; mobile phase flow
rate, 1.5 mL/min; reagent, compound 10 (0.01 M in 0.25 M carbonate buffer, pH 9.5);
reactor temperature, 80 °C; detector wavelength, 610 nm.
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Initial Evaluation of Fluorescein Dialdehyde (6a) as a Postcolumn Reagent
Conditions (Figure 10a): mobile phase, HPLC grade H2O; mobile phase flow rate, 1.5 mL/
min; reagent, compound 6a (6.4 × 10−6 M in carbonate buffer 0.125 M, pH 9.5); reagent
delivery pressure, 40 psi; reactor temperature, 80 °C; detector wavelength, 510 nm.
Conditions (Figure 10b): mobile phase, 0.05% TFA; reagent delivery pressure, 60 psi; all
the other conditions are the same as for Figure 10a.
Compound 6a as Postcolumn Reagent for the Detection of Hcy in Human Plasma
For the HPLC experiments described in Figure 11, the plasma was reconstituted with
distilled water, treated with TFA, and filtered through an Alltech Polypure II 0.2 µm filter.
Conditions: mobile phase, 0.05% TFA; mobile phase flow rate, 1.0 mL/min; postcolumn
reagent, compound 6a (3.2 × 10−6 M) in 0.125 M carbonate buffer, pH 9.5, and delivered
applying 40 psi; reactor temperature, 80 °C; detector wavelength, 510 nm.
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Figure 1.

Structures of selected bioactive thiols.
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Figure 2.

Absorbance at 400 nm of solutions of 8c with added Cys or Hcy. Only a change in signaling
due to Cys is observed.
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Figure 3.

Top: UV – vis absorbance spectra of 6a (3 × 10−6 M) with varying concentrations of CysGly [(4 × 10−6) – (8 × 10−5 M)] in 0.1 M carbonate buffer, pH 9.5, at room temperature.
Bottom: UV – vis absorbance spectra of 8c (3 × 10−6 M) with varying concentrations of
Cys-Gly [(4 × 10−6) – (8 × 10−5 M)] in 0.1 M carbonate buffer, pH 9.5, at room temperature.
Spectrophotometric changes are insignificant for control dipeptide Gly-Gly (see Supporting
Information).
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Figure 4.

Fluorescence emission spectra of deproteinized plasma solutions; excitation is at 470 nm,
pH 9.5, room temperature. 6a (1.7 × 10−7 M) and 8c (1.3 × 10−4 M) are present. Cys (1.3 ×
10−4 M) is added to all solutions. There is no change in fluorescence emission due to added
Cys. When 1 equiv of Hcy (1.3 × 10−4) is added, there is a change in fluorescence emission.
Addition of 4 equiv more of Hcy produces a further quenching of fluorescence at 525 nm.
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Figure 5.
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Fluorescence emission intensity at 525 nm of solutions of 6a (2 × 10−5 M), 8c (2 × 10−3 M),
and blood plasma containing added Cys (2 × 10−3 M). The concentration of Hcy is varied in
the plasma samples as follows: sample 1 = 0 M, sample 2 = 6 × 10−6 M, sample 3 = 1.3 ×
10−5 M, sample 4 = 1.3 × 10−4 M. As the concentration of Hcy increases, quenching of
fluorescence emission is observed. The error bars are based on three runs. The highest error
value (sample 2) accounts for 1.2 × 10−6 M Hcy. These promising results are currently being
optimized.
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Figure 6.

Selective Hcy detection in human plasma without prior deproteinization. Only the Hcyspiked sample turns blue (added thiol left to right: none, Hcy, Cys, GSH, 4.0 mM final thiol
concentration). Inset: samples before heating.
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Figure 7.

UV – vis absorbance spectra of solutions containing 11 (1.0 × 10−5 M) and different
biological thiols (1.0 × 10−4 M).
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Figure 8.

Chromatogram of a mixture of Cys and Hcy using compound 10 as postcolumn reagent.
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Figure 9.

Chromatograms of mixtures of (a) Cys and Hcy; (b) histidine, methionine, and glutamine;
and (c) lysine, glycine, and serine using 11 as the postcolumn reagent.
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Figure 10.

Chromatograms of mixtures of Cys and Hcy using 6a as postcolumn reagent. (a) separation
using HPLC grade water as mobile phase; (b) separation using 0.05% TFA solution to
improve resolution.
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Figure 11.

(a) Chromatogram of a sample of human plasma using 6a as the postcolumn reagent.
Lyophylized plasma is reconstituted with deionized water (1 mL). The solution is mixed
with 100 µL of TFA and syringe-filtered. It is diluted five times with water before injection.
(b) Chromatogram of a sample of human plasma spiked with Hcy using 6a as postcolumn
reagent. The reconstituted plasma mixed with 100 µL of TFA was diluted 10 times with
water and spiked with Hcy (9.5 nmol of Hcy injected).
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Scheme 1.

Formation of Cys-Derived Thiazolidines and Hcy-Derived Thiazinanes from Fluorescein
Dialdehyde 6a and Monoaldehyde 6b
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Scheme 2.

Products 9a and 9b Have Been Identified in the Reaction of Hcy or Cys, Respectively, with
8c
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Scheme 3.
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Scheme 4.

Electron Transfer from the Hcy Carbon-Centered Radical to Methyl Viologen or Fluorone
Black
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Scheme 5.

Proposed Mechanism for the Formation of Byproducts from Hcy α-Amino Carbon-Centered
Radicals
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method

limitations

monobromobimane labeling

(i) unstable at room temperature and in H2O; (ii) batch-to-batch varying impurity levels; (iii) fluorescent
hydrolysis products produced upon labeling; (iv) gradient and relatively complex elution chromatography
needed

iodoacetamide labeling

(i) cross-reactivity with histidine, tyrosine, and methionine; (ii) promotes loss of NH3 upon reaction with Cys
residues; (iii) reduces mass spectrometric sensitivity

o-phthalaldehyde labeling

(i) highly pH sensitive reaction; (ii) thiol adduct exhibits high photoinstability; (iii) cross-reactivity with many
other amino acids

maleimide labeling

(i) hydrolysis peaks are encountered at the beginning and end of chromatographic elution; (ii) cross-linking to
amines; (iii) unwanted rearrangements of conjugates

hexaiodoplatinate labeling

broad cross-reactivity with interferences, including thioethers, thiazolidines and ascorbic acid
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Product

Calcd.

Found

MALDI Matrix

360.53

359.02

none

190.28

190.05
191.01

Anthracene
Dithranol

112.04

112.52

none

156.14

156.68
155.28

Dithranol

138.19

138.23

Dithranol

282.06

283.33

Anthracene

190.17

190.05
191.01

Anthracene
Dithranol

206.28

205.20

Anthracene

None
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a The products highlighted in Scheme 5 have been identified by MALDI MS. They are formed under mild conditions: neutral buffer solution in the
presence of 11 at room temperature.
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